A former sales representative of the biotech firm MiMedx, who faced legal action earlier this year for joining a competitor, has filed a counterclaim against her former employer. According to her statement, she was forced out due to her refusal to participate in practices that allegedly involved flouting U.S. Food and Drug Administration (FDA) regulations and engaging in rampant overbilling schemes.
In her counterclaim, filed on Tuesday, the former employee asserts that she was pressured to leave her position after she refused to comply with these fraudulent activities. The case underscores ongoing concerns about the compliance practices within MiMedx, a company that has previously faced scrutiny and controversy. For more details on this unfolding legal dispute, read the full article on Law360.